Canadian pediatric lupus severity varies with ethnicity

Canadian pediatric lupus severity varies with ethnicity
While Canadian children with systemic lupus erythematosus differ in disease characteristics and severity by ethnicity, treatment, disease activity, and irreversible organ damage are similar across ethnic groups, according to a study published in the January issue of Arthritis Care & Research.

(HealthDay)—While Canadian children with systemic lupus erythematosus (SLE) differ in disease characteristics and severity by ethnicity, treatment, disease activity, and irreversible organ damage are similar across ethnic groups, according to a study published in the January issue of Arthritis Care & Research.

Deborah M. Levy, M.D., from the Hospital for Sick Children in Toronto, and colleagues analyzed ethnicity, sociodemographics, and disease characteristics in 213 Canadian children with childhood-onset SLE. The ethnic composition was 31 percent white, 30 percent Asian, 15 percent South Asian, 10 percent black, 4 percent Latino/Hispanic, 4 percent Aboriginal, and 3 percent Arab/Middle Eastern.

The researchers found that disease manifestations (malar rash, arthritis, serositis, renal disease), autoantibody profiles, and severity of disease expression differed by ethnicity. Only 20 percent of whites had severe disease, compared with 51 percent of Asian patients and 41 percent of black patients. However, disease activity indices, irreversible organ damage, and treatment (76 percent receiving prednisone, 86 percent receiving antimalarials, and 56 percent requiring additional immunosuppressants) were similar across ethnicities.

"Canadian childhood-onset SLE patients reflect our multiethnic population, with differences in disease manifestations, autoantibody profiles, and severity of disease expression by ethnicity," Levy and colleagues write. "We did not observe differences in the measured outcomes of treatment, disease activity, and irreversible . These findings would suggest that universal access to health care in Canada is an important determinant of positive outcomes in childhood-onset SLE."

More information: Abstract
Full Text

Related Stories

Recommended for you

New test could predict arthritis drug failure in patients

date Jul 03, 2015

A study of 311 patients by The University of Manchester has found that it may be possible to predict early which rheumatoid arthritis (RA) patients will fail to respond to the biologic drugs given to treat them. These findings ...

About 8 percent of SLE patients have pulmonary HTN

date Jun 23, 2015

(HealthDay)—About 8 percent of patients with systemic lupus erythematosus (SLE) have pulmonary hypertension (PH), and serum uric acid (UA) has reasonable accuracy for predicting PH, according to a study ...

Early age of menopause linked to seropositivity in RA

date Jun 17, 2015

(HealthDay)—In women with early rheumatoid arthritis (RA), early age at menopause is associated with seropositivity, according to a study published in the May issue of Arthritis Care & Research.

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.